[Postoperative Outcomes with and without Neoadjuvant Denosumab in Grade-III Giant Cell Tumor of the Proximal Femur: A Comparative Retrospective Study]
{{output}}
Objective: To retrospectively compare the impact of using neoadjuvant denosumab for Campanacci grade-III giant cell tumor (GCT) of the proximal femur involving the hip joint. ... ...
